Additionally, oestrogen sensitivity (indicated by ESR1 expression) in HG men is influenced by available oestrogen and those with obesity-induced hyperestrogenemia have reduced E2 sensitivity relative to HG men with lower E2, resulting in a variable response to T therapy. The gene discussed is ESR1; the disease is obesity disorder.